Anoro Ellipta

Anoro Ellipta Dosage/Direction for Use

umeclidinium + vilanterol

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig Pharma
Full Prescribing Info
Dosage/Direction for Use
Posology: Adults: The recommended dose is one inhalation of ANORO 62.5/25 micrograms once daily.
ANORO should be administered once daily at the same time of the day each day to maintain bronchodilation. The maximum dose is one inhalation of ANORO 62.5/25 micrograms once daily.
Special populations: Elderly patients: No dosage adjustment is required in patients over 65 years.
Renal impairment: No dosage adjustment is required in patients with renal impairment.
Hepatic impairment: No dosage adjustment is required in patients with mild or moderate hepatic impairment. The use of ANORO has not been studied in patients with severe hepatic impairment and should be used with caution.
Paediatric population: There is no relevant use of ANORO in the paediatric population (under 18 years of age) for the indication of COPD.
Method of administration: ANORO is for inhalation use only.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in